Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group.
de Lédinghen V, et al. Among authors: foucher j.
J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0.
J Hepatol. 2002.
PMID: 11983451
Clinical Trial.